Advertisement
Screener

Grace Therapeutics, Inc. (GRCE) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Grace Therapeutics, Inc. Capital Expenditures

Grace Therapeutics, Inc. (GRCE) reported Capital Expenditures of $36.00 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-13.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-08-13

  • Grace Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $36.00K, a 89.47% increase year-over-year.
  • Grace Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-03-31 was $319.00K, a 40.26% decline year-over-year.
  • Grace Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $19.00K.
  • Grace Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $534.00K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 month
2020-06-30$36.00K
10-Q · filed 2020-08-13
$355.00K
derived: sum of 2 quarters · filed 2020-08-13
2020-03-31$319.00K
10-K · filed 2020-06-29
2019-06-30$19.00K
10-Q · filed 2020-08-13
$553.00K
derived: sum of 2 quarters · filed 2020-08-13
2019-03-31$534.00K
10-K · filed 2020-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
VERU INC. (VERU)United States$0.043B-3.93
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98